CHEBI:59295 - β-D-Galp-(1→3)-[α-L-Fucp-(1→4)]-β-D-GlcpNAc

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name β-D-Galp-(1→3)-[α-L-Fucp-(1→4)]-β-D-GlcpNAc
ChEBI ID CHEBI:59295
ChEBI ASCII Name beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcpNAc
Definition A β-D-Galp-(1→3)-[α-L-Fucp-(1→4)]-D-GlcpNAc where the N-acetyl-D-glucosamine at the reducing end has β-configuration at its anomeric centre.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C20H35NO15
Net Charge 0
Average Mass 529.48960
Monoisotopic Mass 529.20067
InChI InChI=1S/C20H35NO15/c1-5-10(25)12(27)14(29)19(32-5)35-16-8(4-23)33-18(31)9(21-6(2)24)17(16)36-20-15(30)13(28)11(26)7(3-22)34-20/h5,7-20,22-23,25-31H,3-4H2,1-2H3,(H,21,24)/t5-,7+,8+,9+,10+,11-,12+,13-,14-,15+,16+,17+,18+,19-,20-/m0/s1
InChIKey CFDVGUXRLQWLJX-LPHOMBEVSA-N
SMILES C[C@@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](NC(C)=O)[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@@H]1O
Roles Classification
Biological Role(s): epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
(via beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcpNAc )
antigen
Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC).
(via beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcpNAc )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing β-D-Galp-(1→3)-[α-L-Fucp-(1→4)]-β-D-GlcpNAc (CHEBI:59295) is a β-D-Galp-(1→3)-[α-L-Fucp-(1→4)]-D-GlcpNAc (CHEBI:62265)
Incoming β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminide (CHEBI:140304) has functional parent β-D-Galp-(1→3)-[α-L-Fucp-(1→4)]-β-D-GlcpNAc (CHEBI:59295)
β-D-Galp-(1→3)-[α-L-Fucp-(1→4)]-β-D-GlcpNAc-yl group (CHEBI:88151) is substituent group from β-D-Galp-(1→3)-[α-L-Fucp-(1→4)]-β-D-GlcpNAc (CHEBI:59295)
IUPAC Name
α-L-fucopyranosyl-(1→4)-[β-D-galactopyranosyl-(1→3)]-2-acetamido-2-deoxy-β-D-glucopyranose
Synonyms Sources
6-deoxy-α-L-galactopyranosyl-(1→4)-[β-D-galactopyranosyl-(1→3)]-2-acetamido-2-deoxy-β-D-glucopyranose IUPAC
α-L-fucosyl-(1→4)-[β-D-galactosyl-(1→3)]-N-acetyl-β-D-glucosamine ChEBI
β-D-Gal-(1→3)-[α-L-Fuc-(1→4)]-β-D-GlcNAc ChEBI
Fuca1-4(Galb1-3)GlcNAcb ChEBI
Fucα1-4(Galβ1-3)GlcNAcβ ChEBI
Galβ1,3(Fucα1,4)GlcNAcβ ChEBI
Galβ1-3(Fucα1-4)GlcNAcβ ChEBI
Lea ChEBI
Lewis a trisaccharide ChEBI
O-6-deoxy-α-L-galactopyranosyl-(1→4)-O-[β-D-galactopyranosyl-(1→3)]-2-(acetylamino)-2-deoxy-β-D-glucopyranose ChEBI
WURCS=2.0/3,3,2/[a2122h-1b_1-5_2*NCC/3=O][a2112h-1b_1-5][a1221m-1a_1-5]/1-2-3/a3-b1_a4-c1 GlyTouCan
Manual Xrefs Databases
G39023AU GlyGen
G39023AU GlyTouCan
View more database links
Registry Numbers Types Sources
9105484 Beilstein Registry Number Beilstein
9105484 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
10992504 PubMed citation Europe PMC
19443021 PubMed citation Europe PMC
24749871 PubMed citation Europe PMC
25568069 PubMed citation Europe PMC
31537530 PubMed citation Europe PMC
32568414 PubMed citation Europe PMC
8737251 PubMed citation Europe PMC
Last Modified
27 April 2023